The biology of cancer stem cells

Annual Review of Cell and Developmental Biology

Volumn 23, Issue , 2007, Pages 675-699

  Lobo, Neethan A ^a,b   Shimono, Yohei ^b   Qian, Dalong ^b   Clarke, Michael F ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differentiation; Oncogenesis; Progenitor; Self renewal; Signaling

Indexed keywords

BETA CATENIN; BMI1 PROTEIN; HOX PROTEIN; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TELOMERASE; WNT PROTEIN;

CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL RENEWAL; CELL TRANSFORMATION; CENTRAL NERVOUS SYSTEM; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; MOUSE; NEOPLASM; PHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; MICE; NEOPLASMS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION;

EID: 34548831213     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.22.010305.104154     Document Type: Review

References (134)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100:3983-88
2. Allsopp RC, Morin GB, DePinho R, Harley CB, Weissman IL. 2003. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102:517-20
3. Altman J. 1966. Proliferation and migration of undifferentiated precursor cells in the rat during postnatal gliogenesis. Exp. Neurol. 16:263-78
4. Altman J, Das GD. 1965. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J. Comp. Neurol. 124:319-35
5. Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, et al. 2006. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442:823-26
6. Athar M, Tang X, Lee JL, Kopelovich L, Kim AL. 2006. Hedgehog signalling in skin development and cancer. Exp. Dermatol. 15:667-77
7. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. 2006. Glioma stem cells promote radio-resistance by preferential activation of the DNA damage response. Nature 444:756-60
8. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. 2005. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 65:3025-29
9. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. 1992. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 89:2804-8
10. Bayani J, Selvarajah S, Maire G, Vukovic B, Al-Romaih K, et al. 2007. Genomic mechanisms and measurement of structural and numerical instability in cancer cells. Semin. Cancer Biol. 17:5-18
11. Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, et al. 2001. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat. Immunol. 2:172-80
12. Blair A, Hogge DE, Ailles LE, Lansdorp PM, Sutherland HJ. 1997. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89:3104-12
13. -. Blood 92:4325-35
14. Blair A, Sutherland HJ. 2000. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp. Hematol. 28:660-71
15. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-52
16. Bonnet D, Dick JE. 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3:730-37
17. Brendel C, Mohr B, Schimmelpfennig C, Muller J, Bornhauser M, et al. 1999. Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias. Leukemia 13:1770-75
18. Bruce WR, Van Der Gaag H. 1963. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199:79-80
19. Cairns J. 1981. The origin of human cancers. Nature 289:353-57
20. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841-46
21. Chan EF, Gat U, McNiff JM, Fuchs E. 1999. A common human skin tumour is caused by activating mutations in β-catenin. Nat. Genet. 21:410-13
22. Cheng T, Rodrigues N, Shen H, Yang YG, Dombkowski D, et al. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287:1804-8
23. Chiba S. 2006. Notch signaling in stem cell systems. Stem Cells 24:2437-47
24. Chow LM, Baker SJ. 2006. PTEN function in normal and neoplastic growth. Cancer Lett. 241:184-96
25. Clarke MF. 2004. Chronic myelogenous leukemia: identifying the hydra's heads. N. Engl. J. Med. 351:634-36
26. Clarke MF, Fuller M. 2006. Stem cells and cancer: two faces of eve. Cell 124:1111-15
27. Cobaleda C, Gutierrez-Cianca N, Perez-Losada J, Flores T, Garcia-Sanz R, et al. 2000. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia. Blood 95:1007-13
28. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. 2005. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65:10946-51
29. Collins AT, Habib FK, Maitland NJ, Neal DE. 2001. Identification and isolation of human prostate epithelial stem cells based on α2β1- integrin expression. J. Cell Sci. 114:3865-72
30. Copland M, Jorgensen HG, Holyoake TL. 2005. Evolving molecular therapy for chronic myeloid leukaemia: Are we on target? Hematology 10:349-59
31. - progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res. 60:4403-11
32. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, et al. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1921-29
33. Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. 2003. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17:3029-35
34. Damjanov I. 1993. Teratocarcinoma: neoplastic lessons about normal embryogenesis. Int. J. Dev. Biol. 37:39-46
35. de Lau W, Barker N, Clevers H. 2007. WNT signaling in the normal intestine and colorectal cancer. Front. Biosci. 12:471-91
36. Dirks PB. 2006. Cancer: stem cells and brain tumours. Nature 444:687-88
37. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. 2003. Stem cells in normal breast development and breast cancer. Cell Prolif. 36(Suppl. 1):59-72
38. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, et al. 2005. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65:9328-37
39. Fialkow PJ. 1972. Use of genetic markers to study cellular origin and development of tumors in human females. Adv. Cancer Res. 15:191-226
40. Fialkow PJ. 1990. Stem cell origin of human myeloid blood cell neoplasms. Verh. Dtsch. Ges. Pathol. 74:43-47
41. Fialkow PJ, Martin PJ, Najfeld V, Penfold GK, Jacobson RJ, Hansen JA. 1981. Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 58:158-63
42. Fidler IJ, Hart IR. 1982. Biological diversity in metastatic neoplasms: origins and implications. Science 217:998-1003
43. Fidler IJ, Kripke ML. 1977. Metastasis results from preexisting variant cells within a malignant tumor. Science 197:893-95
44. Fischbach NA, Rozenfeld S, Shen W, Fong S, Chrobak D, et al. 2005. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. Blood 105:1456-66
45. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, et al. 2004. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64:7011-21
46. - bone marrow progenitor population in children with acute lymphoblastic leukemia. Blood 97:3925-30
47. Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, et al. 2005. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 7:967-76
48. Gil-Perotin S, Marin-Husstege M, Li J, Soriano-Navarro M, Zindy F, et al. 2006. Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. J. Neurosci. 26:1107-16
49. Grady WM, Markowitz S. 2000. Genomic instability and colorectal cancer. Curr. Opin. Gastroenterol. 16:62-67
50. Greaves MF, Verbi W, Reeves BR, Hoffbrand AV, Drysdale HC, et al. 1979. "Pre-B" phenotypes in blast crisis of Ph1 positive CML: evidence for a pluripotential stem cell "target". Leuk. Res. 3:181-91
51. Hamburger AW, Salmon SE. 1977. Primary bioassay of human tumor stem cells. Science 197:461-63
52. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, et al. 2006. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24:506-13
53. Heng HH, Stevens JB, Liu G, Bremer SW, Ye KJ, et al. 2006. Stochastic cancer progression driven by non-clonal chromosome aberrations. J. Cell Physiol. 208:461-72
54. Heppner GH. 1984. Tumor heterogeneity. Cancer Res. 44:2259-65
55. Hill RP. 2006. Identifying cancer stem cells in solid tumors: case not proven. Cancer Res. 66:1891-95
56. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN.2000. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25:55-57
57. Hope KJ, Jin L, Dick JE. 2004. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat. Immunol. 5:738-43
58. Huntly BJ, Gilliland DG. 2005. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat. Rev. Cancer 5:311-21
59. Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, et al. 2004. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6:587-96
60. Illmensee K, Mintz B. 1976. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc. Natl. Acad. Sci. USA 73:549-53
61. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, et al. 2004a. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351:657-67
62. Jamieson CH, Weissman IL, Passegue E. 2004b. Chronic versus acute myelogenous leukemia: a question of self-renewal. Cancer Cell 6:531-33
63. INK4a. Nature 443:421-26
64. Johansson CB, Svensson M, Wallstedt L, Janson AM, Frisen J. 1999. Neural stem cells in the adult human brain. Exp. Cell Res. 253:733-36
65. Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, et al. 2000. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14:1777-84
66. Kendall SD, Linardic CM, Adam SJ, Counter CM. 2005. A network of genetic events sufficient to convert normal human cells to a tumorigenic state. Cancer Res. 65:9824-28
67. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-15
68. Kirschenbaum B, Nedergaard M, Preuss A, Barami K, Fraser RA, Goldman SA. 1994. In vitro neuronal production and differentiation by precursor cells derived from the adult human forebrain. Cereb. Cortex 4:576-89
69. Kolligs FT, Hu G, Dang CV, Fearon ER. 1999. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19:5696-706
70. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, et al. 2006. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443:453-57
71. Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, et al. 2006. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442:818-22
72. Kukekov VG, Laywell ED, Suslov O, Davies K, Scheffler B, et al. 1999. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp. Neurol. 156:333-44
73. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, et al. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 17:645-48
74. Lavau C, Szilvassy SJ, Slany R, Cleary ML. 1997. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16:4226-37
75. Lawrence HJ, Helgason CD, Sauvageau G, Fong S, Izon DJ, et al. 1997. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89:1922-30
76. Lessard J, Sauvageau G. 2003a. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255-60
77. Lessard J, Sauvageau G. 2003b. Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis. Exp. Hematol. 31:567-85
78. Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, et al. 2004. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428:337-41
79. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, et al. 2007. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N. Engl. J. Med. 356:217-26
80. Martin PJ, Najfeld V, Fialkow PJ. 1982. B-lymphoid cell involvement in chronic myelogenous leukemia: implications for the pathogenesis of the disease. Cancer Genet. Cytogenet. 6:359-68
81. McClay DR. 1991. Gastrulation. Curr. Opin. Genet. Dev. 1:191-95
82. Mintz B, Illmensee K. 1975. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 72:3585-89
83. Miyamoto T, Weissman IL, Akashi K. 2000. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl. Acad. Sci. USA 97:7521-26
84. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. 2003. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425:962-67
85. Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, et al. 2006. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443:448-52
86. Morrison SJ, Kimble J. 2006. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441:1068-74
87. Morrison SJ, Prowse KR, Ho P, Weissman IL. 1996. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5:207-16
88. Morrison SJ, Qian D, Jerebek L, Thiel BA, Park I-K, et al. 2002. A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. J. Immunol. 168:635-42
89. Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, et al. 1996. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat. Genet. 12:154-58
90. Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G, et al. 2003. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med. 9:439-47
91. O'Brien CA, Pollett A, Gallinger S, Dick JE. 2007. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-10
92. Ohtani N, Yamakoshi K, Takahashi A, Hara E. 2004. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. J. Med. Invest. 51:146-53
93. Pagano SF, Impagnatiello F, Girelli M, Cova L, Grioni E, et al. 2000. Isolation and characterization of neural stem cells from the adult human olfactory bulb. Stem Cells 18:295-300
94. Palma V, Lim DA, Dahmane N, Sanchez P, Brionne TC, et al. 2005. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development 132:335-44
95. Pardal R, Clarke MF, Morrison SJ. 2003. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3:895-902
96. Park CH, Bergsagel DE, McCulloch EA. 1971. Mouse myeloma tumor stem cells: a primary cell culture assay. J. Natl. Cancer Inst. 46:411-22
97. Park IK, He Y, Lin F, Laerum OD, Tian Q, et al. 2002. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood 99:488-98
98. Park IK, Morrison SJ, Clarke MF. 2004. Bmi1, stem cells, and senescence regulation. J. Clin. Invest. 113:175-79
99. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, et al. 2003. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423:302-5
100. Pierce GB, Wallace C. 1971. Differentiation of malignant to benign cells. Cancer Res. 31:127-34
101. Pincus DW, Harrison-Restelli C, Barry J, Goodman RR, Fraser RA, et al. 1997. In vitro neurogenesis by adult human epileptic temporal neocortex. Clin. Neurosurg. 44:17-25
102. Pine SR, Wiemels JL, Jayabose S, Sandoval C. 2003. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia. Leuk. Res. 27:155-64
103. Potter VR. 1978. Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br. J. Cancer 38:1-23
104. Read TA, Hegedus B, Wechsler-Reya R, Gutmann DH. 2006. The neurobiology of neurooncology. Ann. Neurol. 60:3-11
105. Reguart N, He B, Taron M, You L, Jablons DM, Rosell R. 2005. The role of Wnt signaling in cancer and stem cells. Fut. Oncol. 1:787-97
106. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, et al. 2003. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423:409-14
107. Reya T, Morrison SJ, Clarke MF, Weissman IL. 2001. Stem cells, cancer, and cancer stem cells. Nature 414:105-11
108. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. 2007. Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-15
109. Rossi DJ, Weissman IL. 2006. Pten, tumorigenesis, and stem cell self-renewal. Cell 125:229-31
110. Roy NS, Benraiss A, Wang S, Fraser RA, Goodman R, et al. 2000. Promoter-targeted selection and isolation of neural progenitor cells from the adult human ventricular zone. J. Neurosci. Res. 59:321-31
111. Ruiz i Altaba A, Sanchez P, Dahmane N. 2002. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev. Cancer 2:361-72
112. Saeboe-Larssen S, Fossberg E, Gaudernack G. 2006. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol. Biol. 7:26
113. Sanai N, Alvarez-Buylla A, Berger MS. 2005. Neural stem cells and the origin of gliomas. N. Engl. J. Med. 353:811-22
114. Sanai N, Tramontin AD, Quinones-Hinojosa A, Barbaro NM, Gupta N, et al. 2004. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 427:740-44
115. Sawa M, Yamamoto K, Yokozawa T, Kiyoi H, Hishida A, et al. 2005. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int. J. Hematol. 82:42-47
116. Scrideli CA, Simoes AL, Defavery R, Bernardes JE, Duarte MH, Tone LG. 1997. Childhood B lineage acute lymphoblastic leukemia clonality study by the polymerase chain reaction. J. Pediatr. Hematol. Oncol. 19:516-22
117. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. 2003. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63:5821-28
118. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. 2004. Identification of human brain tumour initiating cells. Nature 432:396-401
119. So CW, Karsunky H, Wong P, Weissman IL, Cleary ML. 2004. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. Blood 103:3192-99
120. Somervaille TC, Cleary ML. 2006. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10:257-68
121. Spangrude GJ, Heimfeld S, Weissman IL. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241:58-62
122. Taipale J, Beachy PA. 2001. The Hedgehog and Wnt signalling pathways in cancer. Nature 411:349-54
123. Tamaki S, Eckert K, He D, Sutton R, Doshe M, et al. 2002. Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J. Neurosci. Res. 69:976-86
124. Tavil B, Cetin M, Tuncer M. 2006. CD34/CD117 positivity in assessment of prognosis in children with myelodysplastic syndrome. Leuk. Res. 30:222-24
125. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, et al. 2005. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8:323-35
126. Till JE, McCulloch CE. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14:213-22
127. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, et al. 2000. Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. USA 97:14720-25
128. Virchow R. 1858. Die Cellularpathologie in ihrer Begrundung auf physiologische und pathologische Gewebelehre. Berlin: August Hirschwald
129. Vogler LB, Crist WM, Vinson PC, Sarrif A, Brattain MG, Coleman MS. 1979. Philadelphia-chromosome-positive pre-B-cell leukemia presenting as blast crisis of chronic myelogenous leukemia. Blood 54:1164-70
130. Wagner K, Zhang P, Rosenbauer F, Drescher B, Kobayashi S, et al. 2006. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy. Proc. Natl. Acad. Sci. USA 103:6338-43
131. Wechsler-Reya R, Scott MP. 2001. The developmental biology of brain tumors. Annu. Rev. Neurosci. 24:385-428
132. Xin ZT, Beauchamp AD, Calado RT, Bradford JW, Regal JA, et al. 2006. Functional characterization of natural telomerase mutations found in patients with hematological disorders. Blood 109:524-32
133. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, et al. 2006. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441:475-82
134. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, et al. 2006. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441:518-22